Rénergie H.C.F. Triple Serum

WHAT IT ISTriple-dose serum to help improve volume loss, visibly reduce wrinkles, and brighten dark spot appearance. With its unique triple-chamber packaging and masterful combination of ingredients, this revolutionary anti-aging serum strikes a balance between being highly efficacious while also providing a gentle experience for the skin. 1.69 oz. Made in France. WHAT IT DOESThe expert combination of ingredients in this formula, represented by the name H.C.F, Hyaluronic Acid, Vitamin C+ Niacinamide, and Ferulic Acid, is designed to deliver optimal anti-aging benefits without being harsh on the skin. This triple-serum formulation uses a safe and balanced approach, designed with ingredient concentrations that complement each other within the formula and avoid causing skin sensitivity or irritation. In this innovative triple-chamber packaging, each of the three serums is housed in its own chamber. With each pump of the product, the ingredients from the three chambers are freshly mixed. This helps to maintain higher levels of potency and stability than if the ingredients were formulated in the same chamber. This is the first triple-dose serum of its kind on the market, targeting visible improvement of aging signs, layer by layer. HOW TO USE ITUse daily, in morning skincare routine and evening skincare routine. Holding the product horizontally over the palm of hand or fingertips, press down on the pump until the 3 formulas appear. For one application, dispense 2 pumps into the hand. Mix together in hand until the three formulas are blended into a single serum texture. Apply serum on a clean face and neck using outward and upwards motions for a visibly-lifted effect. Follow with usual moisturizer and eye cream. RESEARCH RESULTSSkin is more supple (+14.7%), Skin is smoother (+30.1%), Fine lines are reduced (-13.8%), Wrinkles are reduced (-7.6%)* , Dark spots are visibly smaller (-14.1%) and less intense (-15.0%). Skin is firmer and less saggy (-12.0%). *Based on 8-week results in a clinical study of 45 women. *Based on 12-week results in a clinical study of 50 women.